HENDERSON, Nevada, May 29, 2024
/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX)
("Volition"), a multi-national epigenetics company, announced today
that Cameron Reynolds, President and
Group Chief Executive Officer, will present and be available for
one-to-one meetings at the Jefferies Global Healthcare Conference
in New York City.
Presentation Details:
Date: Wednesday, June 5, 2024
Time: 3.30 pm ET (Track 3)
Cameron Reynolds, President and
Group CEO of Volition, said: "We are dedicated to improving
outcomes for people and animals with life-altering diseases such as
sepsis and cancer through earlier detection, disease and treatment
monitoring. We look forward to presenting our extensive portfolio
of patented epigenetic technologies at the Jefferies Global
Healthcare Conference."
Investors can schedule a one-to-one meeting with Volition's
Executive Team by emailing investorrelations@volition.com.
About Volition
Volition is a multi-national company focused on advancing the
science of epigenetics. Volition is dedicated to saving lives and
improving outcomes for people and animals with life-altering
diseases through earlier detection, as well as disease and
treatment monitoring.
Through its subsidiaries, Volition is developing and
commercializing simple, easy to use, cost-effective blood tests to
help diagnose and monitor a range of diseases, including some
cancers and diseases associated with NETosis, such as sepsis. Early
diagnosis and monitoring have the potential not only to prolong the
life of patients, but also improve their quality of life.
Volition's research and development activities are centered in
Belgium, with an innovation
laboratory and office in the U.S. and additional offices in
London and Singapore.
The contents found at Volition's website address are not
incorporated by reference into this document and should not be
considered part of this document. Such website address is
included in this document as an inactive textual reference
only.
Media Enquiries:
Louise
Batchelor/Debra Daglish,
Volition, mediarelations@volition.com +44 (0)7557 774620
View original
content:https://www.prnewswire.com/news-releases/volitionrx-limited-to-present-at-jefferies-global-healthcare-conference-302157932.html
SOURCE VolitionRx Limited